More dillution and then eventually a reverse split to bring number of shares down. The only thing that propel this type of stock is either great trial data Or a buyout. The question is how much longer until Phase 2 data? Any guess. I do agree with others, this move ALWAYS hurts the investor unless you buy more on the dip and trial news comes out soon! GLTA!
They've already done two reverse splits, and I doubt they will make any hesitiation to do it again. They call for phase II AMR- results this year. Still, it's so speculative and vague with patience running way too thin considering. You are correct.